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Background: Scaling protein production seems like a simple perturbation of transcriptional control.
However, when embryonic tendon ﬁbroblasts have to produce 450% procollagen and secrete it from the
cell 4 times faster than the average protein, this taxes the cellular machinery and requires a fresh look at
how the pathway is controlled. Ascorbate, a reducing agent, can stimulate procollagen production 6-fold.
Procollagen mRNA levels goes up 6-fold but requires 3 days for the cell to accomplish this task. Secretion
rates, the last cellular step in the process, also goes up 6-fold but this occurs in o1 h. What regulatory
scheme is consistent with these properties?
Scope of this review: This review focuses on ﬁbroblasts that make high levels of procollagen (type I) and
how they regulate the collagen pathway. Data frommany different labs are relevant to this problem but it
is hard to see the bigger picture from a large number of small studies. This review aims to consolidate
this data into a coherent model and this requires solutions to some controversies and postulating po-
tential mechanisms where the details are still missing.
Major conclusions: In high collagen producing cells, the pathway is controlled by post-transcriptional
regulation. This requires feedback control between secretion and translation rates that is based on the
helical structure of the procollagen molecule and additional tissue-speciﬁc modiﬁcations.
General signiﬁcance: Transcriptional control does not scale well to high protein production with rapid
regulation. New paradigms lead to better understanding of collagen diseases and tendon morphogenesis.
& 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2. Collagen regulation in high producing cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.1. Transcription . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.2. Secretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.3. Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4. Ascorbate, P4-H, and cell density . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2.5. Hypothesis on translational control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.6. Transcription revisited. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3. Cell density and morphogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Appendix A. Supplementary material. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43B.V. This is an open access article
doplasmic reticulum; P4-H,1. Introduction
Type I collagen is the most abundant protein in vertebrates
being 90% of the organic component of bones, tendons, and li-
gaments [1,2]. This collagen forms ﬁbers that are best known forunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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usually considered a simple variable, so little respect is given to
cells for expressing a protein in large amounts. But high produc-
tion puts stress on every part of the cell's machinery. If over half of
the protein made by the cell is procollagen and the genes for the
two chains are present in the genome as a single copy, what
modiﬁcations are needed to make sufﬁcient mRNA? If the cell
secretes this protein, and the average cell secretes about 10% of its
proteins, can the cell just speed up the assembly line and secrete
60–70%? Then there is the problem of control. Once the cell gets
everything going at high speed, how does the cell rapidly slow
production down and then speed it up again? In a tendon, for
instance, the length of the tissue is critical for function and it is
changing at every stage of development. A tendon that is too long
or too short will not allow the muscle to accurately control the
bone. A tendon that is too wide cannot act as spring and tendon
that is too narrow will break. Therefore, controlling collagen pro-
duction is critical in forming a functional collagen rope. So how do
the regulatory mechanisms in high collagen producing cells differ
from cells making relatively low levels?
Nature has supplied a highly speciﬁc inducer of collagen pro-
duction, ascorbate (vitamin C, ascorbic acid). Ascorbate acts as a
reducing agent, being especially suited to reducing ferric to ferrous
[3]. This ability of ascorbate can increase procollagen production
and secretion by 6-fold when cells are at a moderate to high cell
density [4,5]. In this review, nature's use of a reducing agent rather
than a transcription factor to regulate type I collagen will be ex-
plained. This will require a focus on the feedback regulation be-
tween secretion rates and translation rates that depends on the
helical structure of the collagen molecule. In turn, the activity of
the enzyme, prolyl 4-hydroxylase (P4-H; EC 1.14.11.2), required to
stabilize the triple helical conformation of collagen, will be shown
to play a regulatory role. This enzyme uses molecular oxygen and
ferrous ion to catalyze the hydroxylation of 40% of the prolines
in chicken collagen. Keeping ferrous ion reduced in the close
proximity of molecular oxygen is the critical role played by as-
corbate. In normal development in contrast to cell culture, where
ascorbate levels are not limiting, the prolyl 4-hydroxylase activity
levels become regulatory and the levels are controlled by cell
density signaling. This signaling also controls cell proliferation and
this causes tendon ﬁbrils to grow by way of a cylindrical growth
plate. This combination allows tendon cells to grow at the front of
the growth plate, to make high levels of collagen in the middle,
and apoptosis at the trailing edge. The consequence is that col-
lagen uniformly ﬁlls a tube-like structure giving rise to a ﬁbril that
is the hallmark of this tissue. In the process a major irreversible
transformation (in normal development) occurs whereby cell
growth and differentiation occur on one side of the growth plate
but on the other side, the few cells remaining are in a low growth,
low collagen production, maintenance state.
In this review, we will ﬁll in the details of the outline above and
in doing so try to resolve some of the controversies. Some areas of
the puzzle are only partially ﬁlled in and we will postulate solu-
tions for how they may work.2. Collagen regulation in high producing cells
2.1. Transcription
Regulating a pathway at the ﬁrst step of protein biosynthesis,
transcription, has a logical simplicity: the cell only makes what it
needs and downstream controls are not required [6]. This common
regulatory scheme could be used in regulating collagen in cells
making lower levels of collagen. However, when avian tendon cells
need to produce over 50% of their protein production asprocollagen from single copy genes for the α1 and α2 chains, new
problems are introduced. The ampliﬁcation of a single copy gene
by multiple copies of mRNA compensates for the limited rate at
which a ribosome can translate a mRNA sequence into protein. The
problem with high collagen production is that the cell needs 5000
times more mRNA than for the average protein. There is a limit to
the rate at which the RNA polymerases can make mRNA off of a
single copy gene (processivity). So if it takes minutes to fully in-
duce an average protein, this process will take days to fully induce
an abundant protein.
This is precisely what is observed in primary avian tendon (PAT,
from 16 day embryos) cells. The induction kinetics can be done
because nature has provided an almost speciﬁc inducer of collagen
production, ascorbate. Surprisingly (since nobody knows why this
should be true), chick tendon cells do not make ascorbate, despite
the fact that they have the genes to do so. Instead, chick tendon
cells rely on the liver or kidney to perform this task, and then
secrete ascorbate into the blood, fromwhere it is actively taken up
[7]. As a result, with PAT cells at moderately high cell density (this
requirement is discussed more below), one can add ascorbate and
then follow the 6-fold induction of procollagen production. The
procollagen mRNA goes up 6-fold but takes almost 3 days to lin-
early increase to the fully induced state (a 3-fold increase in
transcription and a 2-fold increase in half-life [10.5–20 h]) [4,8]. So
regulation of collagen production by altering mRNA levels would
be extremely sluggish for an embryonic chick tendon cell where
type I collagen is ﬁrst observed around embryonic day 10 [9] and
the tendons have to be fully functional 11 days later.
2.2. Secretion
In stark contrast to transcription, ascorbate induction of pro-
collagen secretion, the last cellular step in the pathway, is fast. In
less than 60 min the rate increases 6-fold, and as a result, the half-
life (the time it takes for half of the procollagen to leave the cell; a
ﬁrst-order reaction) drops from 120 to 20 min [10]. On the other
hand, non-collagen proteins leave the cell with an average half-life
of 75 min and this is independent of ascorbate [10]. The average
cell secretes about 10% of its total protein production and this rises
to 60% in PAT cells. The net result is that fully induced PAT cells
make over half their total protein production as procollagen and
secrete it almost 4 times faster than the average protein (90% of
the procollagen exits quickly but 10% continues to take the slow
route).
Ascorbate increases the hydroxylation of proline residues in the
collagen part of the procollagen molecule to 40% which is
known to stabilize the collagen triple helix [11–13]. This occurs
because hydroxylation favors pucker conﬁgurations of the proline
rings that stabilize the trans conformation of the adjacent peptide
bonds. This, in turn, is required for a stable collagen triple helix
formation [14,15]. The simplest interpretation of the kinetic data
for collagen secretion is that a triple helical collagen has a faster
route out of the cell than its non-helical counterpart [16,17]. The
kinetics also point to the transport out of the ER as the slow step in
secretion. Because underhydroxylated procollagen can almost all
be hydroxylated by activating P4-H with ascorbate, the pool of
underhydroxylated collagen must be in the ER where P4-H resides
[18,19].
Other observations make procollagen secretion unusual. One
relates to sensitivity of procollagen to endoglycosidase H. Pro-
collagen I has N-linked glycosylations in the C-propeptide which
when made in the ER can be cleaved by endoglycosidase H.
However, these glycosylations are usually rearranged as the pro-
tein goes through the Golgi so that they become resistant to the
enzyme. With collagen, both the cellular form and the secreted
form remain sensitive to endoglycosidase H [20]. Another relates
Fig. 1. Hypothesis for a procollagen secretion model. The model for the fast route
relies on the unusual characteristics of a triple helical procollagen molecule. The
collagen triple helical region is a long and slender cylinder (300 nm1.5 nm). The
N-terminal propeptide (red) forms a hairpin loop and folds back and binds to the
collagen helix. The C-terminal propeptide (green) crystal structure has been de-
termined [46] but it is unclear whether it is ﬂexible enough to slip through a small
pore. We are suggesting that the procollagen molecule could be recognize by a
receptor gatekeeper (blue; the slow step in the process) and go through a pore
(purple) that transverses both the ER and plasma membranes. This would allow a
fast exit from the cell that requires little energy, driven by a diffusion gradient. The
slow route out of the cell is postulated to use vesicles. Packing large helical or non-
helical stranded molecules into vesicles would be a slow process raising the half-
life inside the cell by 6-fold. One can explain why 10% of the triple helical pro-
collagen goes our by the slow method in two ways. If there are many invaginations
within the ER, some may only have the vesicle route. Alternatively, if the pro-
collagen can take either route, then the ratio of vesicles to pores and the relative
speeds of each step will determine the distribution that exits by each route.
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cess. The classic vesicle secretion model would predict that se-
cretion would be very temperature sensitive – moving vesicles
takes energy and these processes should slow with a drop in
temperature. As expected with PAT cells, a 9 °C shift in tempera-
ture (41–32°; over this range secretion still follows ﬁrst order ki-
netics) causes the secretion half-life of non-collagen proteins to
increase 2-fold from 70 to 140 min. Procollagen secretion, both the
fast and slow rates, remains stable over the same 9 °C change in
temperature [21]. In summary, the above studies, from high col-
lagen producing cells, have used kinetic and biochemical studies to
probe procollagen secretion. They are consistent with two modes
of exit from the cell, one of which is very fast, requires a triple
helical collagen region, and the slowest step in the secretion
pathway uses little energy; the other is slow, also the slowest step,
exiting the ER, uses little energy, but does not discriminate on the
helical nature of the collagen part of procollagen molecule.
These studies are in contrast to those using electron micro-
scopy. The vast majority of these studies, but not all of them [22],
conclude that collagen gets secreted using the classical method of
vesicle transport from the ER to the Golgi and then vesicle trans-
port to the plasma membrane [23–25]. The two techniques are
very different: the kinetic studies reveal parameters but no details
on the mechanism. The EM studies are a snapshot of a dynamic
process and are biased towards those events that move slowly and
are present in large amounts. Despite their differences, one can
combine the data from both techniques and come up with a rea-
sonable hypothesis for how procollagen secretion works in high
collagen producing cells. The kinetic studies are consistent with
two methods for procollagen secretion – slow and fast. The EM
studies almost always see procollagen being secreted by vesicles
through the Golgi. Electron microscopy studies are best at seeing
slow steps, so we will assign the slow method to vesicle transport
by way of the Golgi. However, kinetic studies have shown that the
slowest step (the rate-limiting) is getting out of the ER. This slow
step is assumed to be relatively temperature independent so it
does not require lots of energy. In PAT cells we can put a time
frame on this process: 120 min half-life to get out of the ER, po-
tentially due to packing very long molecules into vesicles, then a
relatively speedy trip to get to and through the Golgi and on to the
plasma membrane (Fig. 1). Even when PAT cells are given ascor-
bate and all the procollagen is fully hydroxylated, 10% still goes
out by way of the slow route [10]. One can visualize this as a
consequence of the ER having lots of invagination and roughly 10%
only allow secretion by the slow process, or two competitive
routes and vesicles are only 10% as efﬁcient as the speedier
pathway. Because of the high overall production, this is still a
signiﬁcant amount of procollagen going out through the Golgi and
this is consistent with the electron microscopy observations. A
similar argument would explain the observation that the secreted
collagen's N-linked glycosylations are sensitive to endoglycosidase
H. In this case, not all but only 90% remains sensitive to the en-
zyme and 10% is postulated to go out by way of the Golgi and
become resistant to endoglycosidase H. This difference is hard to
detect by protein gels unless one is really looking for it.
The remaining question is how does procollagen leave the cell
at the fast rate in high collagen producing cells. One observation
may have relevance to this question. PAT cells show a dramatic
change in cell shape when induced with ascorbate to make high
levels of procollagen and this is related to the increased size of the
ER. This increase in the ER is so great that it polarizes the nucleus
to one end of the cell (Fig. 2). This also pushes the ER membrane in
close proximity to the plasma membrane. One could postulate a
pore crossing both membranes with a receptor gate keeper. Even
though a triple helical procollagen molecule would have a high
molecular weight (450 kD), the helical part is contained in along cylinder with a small diameter. The small diameter is im-
portant because a large pore would weaken the integrity of the
membrane. Even the N-terminal propeptide forms a hairpin loop
and folds back on the helical collagen [26,27] and ensures that the
leading edge retains a compact structure. The high concentration
gradient would drive the process without the need for energetic
steps. An alternative mechanism using secretory vesicles could be
postulated whereby the vesicles go directly from the ER to the
plasma membrane. With the expansion of the ER this would be a
very short trip. As a consequence, it could go 6X faster and require
less energy. This model would ﬁt the kinetics but it is unclear how
a vesicle would discriminate between a helical and non-helical
conformations. In any case, the exact mechanism for fast secretion
needs to be resolved.
2.3. Translation
After adding ascorbate, the ﬁrst indication for increased
translation occurs at 3 h [4]. Stimulation of translation is inter-
mediate between the fast change for secretion and the slow
change for transcription. After a 1 h delay to allow ascorbate to
enter the cell, the pool of newly made procollagen would rapidly
go from a non-helical to a helical form. This indicates that the two
forms have the same degradation rates inside the cell since
changes in degradation rates would be reﬂected in the translation
rates. During ascorbate induction, translation rates are tethered to
mRNA levels except that procollagen mRNA pool in the cytoplasm
is used with twice the efﬁciency. This may reﬂect that when P4-H
is in excess that this in itself stimulates translation by 2-fold As a
result the 6-fold increase in protein expression is reached in 48 h
Fig. 2. Ascorbate induction of collagen production in PAT cells causes a dramatic increase in the ER. PAT cells grown without ascorbate (A) and with ascorbate (B) were
labeled with live cell dye highly selective for endoplasmic reticulum (ER-Tracker Blue–White DPX, Molecular Probes). As a consequence of the expansion of the ER in
ascorbate induced cells, the nucleus is polarized to one side of the cell. Also, at this level of resolution, the ER appears to be very close to the plasma membrane. This
expansion of ER could be important for secretion of procollagen and translation of procollagen mRNA.
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becomes rate-limiting. Translational control is revealed better by
inhibiting collagen production in fully induced cells. Ascorbate
cannot be removed from the cell by washing because ascorbate is
actively taken up. Instead, P4-H can be inhibited by chelating
ferrous ion with α,α′-dipyridyl [4,17]. Adding the chelator to fully
induced cells causes 2/3 reduction in procollagen translation re-
lative to non-collagen proteins after 3–4 h. The uninduced cells
show no effect of the chelator on the ratio of collagen to non-
collagen production. However, chelating ferrous ion does have a
non-speciﬁc effect on the cells and this causes all protein synthesis
to drop by one third. Therefore on an absolute scale, one third of
the drop in procollagen production is non-speciﬁc and two thirds
is speciﬁc to procollagen. These results are consistent with a model
where the cell is trying to keep the translation rates equal to the
secretion rates. If the chelator causes a general reduction in pro-
tein synthesis, then the speciﬁc inhibition need only make up the
difference to maintain the equilibrium between these steps. As a
result, inhibition of collagen secretion causes a drop in collagen
translation that restores the equilibrium between these steps in 3–
4 h.
On the outside of the ER there is another important regulation
involving membrane- bound ribosomes making type I procollagen
composed of two α1 and one α2 chains. The genes are not linked,
and are on different chromosomes in humans, so it is unlikely that
the mRNA is made in a precise 2:1 ratio. In the case where the α2
chain is knocked out, and in some mutations, the α1 chain can
form a stable trimer [28–30]. So what dictates the 2:1 ratio of
these chains. One solution would be to have ribosome complexes
with speciﬁcity for speciﬁc mRNAs. Distinct complexes of ribo-
somes have been observed in ﬁbroblasts using electron micro-
scopy [31]. There are reports of enhanced binding of procollagen
ribosomes on the ER by a protein, p180 [32,33]. A critical experi-
ment was done where the DNA sequence for the promoter for type
I collagen was inserted at the front of the type II collagen (carti-
lage) gene and then this construct was expressed in mice [34]. This
directed cells in tissues that speciﬁcally expressed only type I
collagen to now make large amounts of the type II procollagen
mRNA. In well controlled experiments, those cells would not
translate the inappropriate mRNA (o2% compared to collagen
type 1 levels). This translational screening accounts for the lack of
phenotypic change in those mice. While this result is striking, itmakes sense that a cell would have to optimize several steps in a
pathway in order to make high levels of a speciﬁc protein. That
these optimized steps would have speciﬁcity for that protein is not
completely unexpected.2.4. Ascorbate, P4-H, and cell density
At this point ascorbate can be seen as regulating collagen
production by keeping ferrous ion reduced, a requirement for the
enzymatic activity of P4-H, and the resulting hydroxylation of
prolines stabilizes the triple helical form of collagen. But there is a
more dominant factor in this regulation: cell density. As was
pointed out in the discussion above, ascorbate is only added to
cells at a moderate to high cell density to induce the collagen
pathway. At low cell density, adding ascorbate has no effect [5,35].
Cell density turns out to be the key regulator of the collagen
pathway and it works by controlling the level of one of the two
subunits of P4-H [36]. So at low cell density the amount of enzyme
becomes rate-limiting but at high cell density the active enzyme is
6-fold higher and then, ascorbate levels becomes critical for
maintaining enzyme activity. In normal chick development when
ascorbate is always available, cell density through its regulation of
active P4-H levels controls collagen production.
P4-H is an unusual enzyme. In vertebrates it is a tetramer (2α,
2β) [37]. The β-subunit is identical to a protein disulﬁde isomerase
(rearranging disulﬁde bonds) that has multiple roles by itself, in-
cluding being a protein chaperone. The complete enzyme has a
high binding afﬁnity for the single stranded form of collagen and a
low afﬁnity for the helical trimeric form [11,13]. This differential
binding always insures that the level of prolyl hydroxylation is
sufﬁcient to form a stable helix. In general the level of proline
hydroxylation correlates with the denaturation temperature of the
collagen produced [12]. However, the amino acid sequence of the
collagen also inﬂuences helical stability [38].
The α-subunit is controlled by cell density. The 6-fold in-
crease in the α-subunit levels [36] as PAT cells grow from low to
high cell density is not reﬂected in mRNA levels which remain
relatively constant [39]. The cell density effect has been postulated
to stabilize the protein through a change in the redox potential of
the cell [39].
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The basic question is how does a high collagen producing cell
coordinate the level of procollagen translation with its ability to
secrete it? Or phrased from a developmental point of view, if the
cell uses cell density to control P4-H levels how can this syn-
chronize the rates of procollagen secretion and translation? Se-
cretion is relatively simple. The cell has a slow and a fast method
for secreting procollagen out of the ER. The more P4-H is active,
the more procollagen becomes helical in the collagen region and
can use the fast route for secretion. Translation is more compli-
cated. Even physically, P4-H is inside the ER while translation is
occurring on membrane-bound ribosomes on the outside of the
membrane. The one thing that directly links these dominant
players is the newly synthesized procollagen chains. Yet, changes
in the activity of P4-H are sensed by the translational machinery.
We postulate that the unique abilities of P4-H are designed for
this task. First, P4-H has a strong afﬁnity for the non-helical mo-
lecule and binds to it – a chaperone function. Partially due to the
length of the procollagen molecule and the potential for the col-
lagen portion to interact with itself, other newly formed chains,
and other molecules, the role of chaperone could strongly impact
the kinetics of translation. Second, when P4-H hydroxylates pro-
collagen and the collagen region forms a triple helix, the enzyme
loses binding strength and returns to the free pool. In this way the
free pool level is linked to the activity of the enzyme and this in
turn ties P4-H activity to the ability to act as a chaperone and
stimulate translation rates (Fig. 3).
This model can explain the difference in lag time for secretion
and translation induction. On addition of ascorbate there is an
1 h delay for ascorbate to taken up and for P4-H to be activated.
As the conformation of the procollagen in the pool changes, the
helical procollagen gets secreted 6 times faster so it appears as a
switch in rates. In contrast, the activity of the P4-H is not predicted
to affect translation directly. As the triple helical part of procolla-
gen is formed, the P4-H is released to the free pool where it can
now act as a chaperone for newly synthesized procollagen.
Building up the free pool can add another 30 m to the induction
time. Then there is additional time needed to increase synthesis in
order to signiﬁcantly exceed the uninduced level. The net result is
an 3 h lag time.
While this model ﬁts nicely with the known characteristics of
P4-H and with the kinetics of induction, more research is neededFig. 3. Translation rates are tied to the collagen structure within procollagen. We po
translation rates by reducing entanglements with other chains and proteins. Because P4-
prolines to stabilize the helical structure it falls off and rejoins the free pool. Thus, fo
translation. If this is disrupted by a lack of ascorbate or use of a ferrous ion chelator, the P
a consequence, translation slows down.to conﬁrm its validity. Similarly, more research is needed to con-
ﬁrm or deny whether ribosomes are organized so that two α1 and
one α2 chain can be produced in close proximity and whether
hydroxylation and other modiﬁcations are occurring with active
translation [40,41]. Finally, more research is needed to understand
the mechanism driving the expansion of the ER (Fig. 2) so there is
room for more procollagen translation when PAT cells are fully
induced.
2.6. Transcription revisited
As discussed above, transcription is the slowest step in the
ascorbate induction process. There is a lag phase of 8–12 h and
then a linear induction that takes 3 days to increase the level of
procollagen mRNA by 6-fold. The early lag phase seems incon-
sistent with induction by a transcription factor because these
generally work on the order of minutes. Instead, one can speculate
from what is seen inside the ER that pool size has a regulatory
function. On the outside of the ER, as translation increases after
3 h, more of the procollagen mRNA is moving to membrane-bound
ribosomes. This would cause a drop in the free pool in the cyto-
plasm that in turn could draw more mRNA from the nucleus that
in turn could stimulate transcription. Such changes would be
consistent with the slow induction but more experimental data
are needed to clarify the induction of transcription and stabiliza-
tion of procollagen mRNA.3. Cell density and morphogenesis
From the discussion above, cell density is the major regulator of
collagen production in tendon cells. Cell density is also the major
regulator of cell proliferation. These are not new concepts. The
ability of normal cells, as opposed to malignant cells, to limit their
proliferation when they reach a certain cell density is seen both
in vivo and in culture [42]. Similarly, the concept that cells have to
slow their growth before they can differentiate is taken as almost
axiom of cell biology [43]. But this regulation is taken to another
level in chick tendon where these cells have to rapidly build a
collagen rope [44]. Cells sense cell density by using a diffusible
factor, a small protein bound to a tissue-speciﬁc lipid that spends
part of its time bound to the membrane [45]. The higher the cell
density the higher the concentration of the diffusible factor boundstulate that P4-H role as a chaperone to nascent procollagen is critical for rapid
H has a low afﬁnity for triple helical collagen, as soon as it has hydroxylated enough
r a given amount of P4-H an equilibrium is established allowing a certain rate of
4-H remains attached to the single stranded collagen, and the free pool drops and as
Fig. 4. The tendon growth plate is regulated by cell density signaling (CC-BY 3.0 [45]). The signaling is composed of two components: a diffusible molecule (SNZR[sensor] PL,
blue) that spends part of its time bound to the cell membrane is made up of a highly conserved peptide (P) bound to a tissue-speciﬁc lipid (L); a second molecule (SNZR L,
yellow) which we postulate is the tissue-speciﬁc lipid is located in the plasma membrane. The amount of SNZR PL bound to the cell membrane reﬂects the level of cells in the
vicinity. At a moderate cell density the level of SNZR PL is sufﬁcient to fully stimulate proliferation. This level also stimulates the production of the free lipid. SNZR L. As SNZR
L rises relative to the bound SNZR PL, the cell slows growth and raises collagen production allowing the growth plate to ﬁll the “tube” with collagen (shown by oval cells
becoming rectangles). At high levels of SNZR L, the production of the peptide slows. When the level of SNZR L is sufﬁciently high relative to SNZR PL, this triggers apoptosis –
the cells are growing at the front and dying at the back allowing the growth plate to move. Basically, by having these two sensors, the tendon cell knows where it is, what it
should be doing, and how long it has been doing it. All are essential for generating a growth plate. In the ﬁgure, at the bottom, are labels for the different regions of the
growth plate. A few cells at the perimeter of the growth plate never reach a high cell density and escape apoptosis. These cells end up between the ﬁbrils in a low growth,
low collagen production, maintenance state. So the growth plate not only lays down a uniform collagen ﬁbril but it causes a transition from a growing/differentiating state to
a maintenance state.
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allows cells to form a growth plate [44,45]. This was ﬁrst predicted
by mathematically modeling tendon morphogenesis using reg-
ulatory information obtained from experiments with PAT cells in
culture and then conﬁrmed by sectioning tendon tissue from the
embryo and adolescent chicken at the middle of the tendon and at
the muscle/tendon junction [21,44]. The growth plate regulates
collagen production in tube-like structure called a ﬁbril (Fig. 4).
The growth plate is also changing the state of the cells: the tendon
cells in the growth plate are growing and differentiating but the
few cells from the outer edge of the growth plate that escape
apoptosis end up between the ﬁbrils and are in a low growth, low
collagen production, maintenance state. Therefore, cell density
regulation of collagen production is part of a bigger morphogenic
program.4. Conclusions
High production of a single protein requires the cell to change
its regulatory program. Transcription rates are restricted by a
single copy gene and as a result building up large amounts of
mRNA takes days. To overcome this, the cell accumulates large
amounts of procollagen mRNA and then regulates the pathway at a
downstream site.
High production of a secreted protein also requires high se-
cretion rates. Vesicle secretion is slow as seen with non-collagen
proteins and is sensitive to temperature changes. Instead tendon
cells have a secretory route for procollagen with a helical collagen
region that is 6X faster than the non-helical form. This route does
not appear to go through the Golgi since secreted procollagen
remains sensitive to endoglycosidase H and the secretion process
is temperature independent over a 9° range. While we postulate
two models, a pore through both the ER and plasma membrane
with a receptor gate keeper, or vesicles that go directly between
the ER and the plasma membrane, the exact mechanism is
unknown.
To make a post-transcriptional regulatory step, one needs
feedback between steps. Regulation is based on the amount of
active P4-H. As the cells go from low to high cell density, there is a
6-fold increase in secretion and translation rates. To accomplishthis, we postulate that translation rates rise with P4-H levels be-
cause of its ability to act as a chaperone and inhibit aggregation
with itself, other procollagen chains, and other molecules. When
P4-H activity is inhibited by ferrous ion chelators, the non-helical
collagen never releases the P4-H for its role as a chaperone. Thus,
the cell is using the structure of the collagen region to coordinate
the regulation of both secretion and translation.
Because cell density signaling controls collagen production and
cell proliferation, this signaling causes a growth plate to form that
allows collagen to ﬁll a tube with collagen and this is the building
block of tendon morphogenesis.Acknowledgments
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